SCHEMBL27615902

SCHEMBL27615902

Cc1ccc(-c2cccc(C(=O)CC(=O)Nc3cc(C(F)(F)F)c(C)cc3NC(=O)O)c2)cn1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.45
CDK8 P49336 8/20 0.40
RAB9A P51151 2/20 0.40
WNT3A P56704 2/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27615896 0.92 POLB (0.43) POLBCDK8RAB9AWNT3AALDH1A1
SCHEMBL27597124 0.90 POLB (0.41) POLBCDK8RAB9AWNT3AALDH1A1
SCHEMBL27615895 0.90 POLB (0.41) POLBCDK8RAB9AWNT3AALDH1A1
SCHEMBL5557258 0.89 CDK8 (0.39) POLBCDK8WNT3A
SCHEMBL27615930 0.89 POLB (0.42) POLBCDK8RAB9AWNT3AALDH1A1
SCHEMBL28754186 0.89 POLB (0.40) POLBCDK8RAB9AWNT3A
SCHEMBL28751517 0.88 POLB (0.44) POLBCDK8RAB9AWNT3AALDH1A1
SCHEMBL27597121 0.87 POLB (0.46) POLBRAB9AWNT3A
SCHEMBL27597155 0.87 POLB (0.46) POLBRAB9AWNT3A
SCHEMBL27597128 0.86 ALDH1A1 (0.50) POLBRAB9AALDH1A1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed